n,n-dimethylarginine has been researched along with Vascular Diseases in 32 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 11 (34.38) | 29.6817 |
2010's | 17 (53.13) | 24.3611 |
2020's | 4 (12.50) | 2.80 |
Authors | Studies |
---|---|
Bode-Böger, SM; Bornstein, SR; Burdin, D; Chen, Y; Cordasic, N; Hilgers, K; Hofmann, A; Hohenstein, B; Hugo, CPM; Jacobi, J; Jarzebska, N; Kolouschek, A; Maas, R; Markov, AG; Martens-Lobenhoffer, J; Morawietz, H; O'Sullivan, JF; Pfluecke, C; Rodionov, RN; Rubets, E; Todorov, V; Weiss, N | 1 |
Dimitroulas, T; Garyfallos, A; Kitas, GD; Loutradis, C; Malliari, A; Pagkopoulou, E; Soulaidopoulos, S; Triantafyllidou, E | 1 |
Deng, Z; Hu, C; Jia, W; Wang, S; Yan, D; Zhang, H; Zhang, R; Zheng, X | 1 |
Fukuo, K; Imamura, T; Otaki, N; Tanino, N; Yano, M; Yokoro, M | 1 |
Huml, M; Jehlička, P; Kreslová, M; Masopustová, A; Sýkora, J; Trefil, L; Votava, T | 1 |
Brodmann, M; Gary, T; Hackl, G; Hafner, F; Jud, P; Meinitzer, A; Seinost, G; Verheyen, N | 1 |
Ando, R; Fukami, K; Kaida, Y; Kaifu, K; Miyazaki, H; Nakayama, Y; Obara, N; Okuda, S; Takeuchi, M; Ueda, S; Yamagishi, S; Yokoro, M | 1 |
Ballard, KD; Bruno, RS; Guo, Y; Mah, E; Pei, R; Volek, JS | 1 |
Elenkova, A; Kirilov, G; Matrozova, J; Vandeva, S; Vasilev, V; Zacharieva, S | 1 |
Blanco-Colio, LM; Carrero, JJ; Cetinkaya, H; Eyileten, T; Gok, M; Oguz, Y; Saglam, M; Sari, S; Sonmez, A; Unal, HU; Vural, A; Yaman, H; Yildirim, AO; Yilmaz, MI | 1 |
Lappegård, KT; Nestvold, TK; Nielsen, EW; Seljeflot, I; Thoresen, H; Trøseid, M | 1 |
Chaturapanich, G; Lukkhananan, P; Sibmooh, N; Srihirun, S; Swaddiwudhipong, W; Thawonrachat, N; Unchern, S; Visoottiviseth, P; Vivithanaporn, P | 1 |
Arpaci, D; Ciftci, IH; Ergenc, H; Gurol, G; Karakece, E; Tamer, A; Tocoglu, AG | 1 |
Dhondt, A; Glorieux, G; Leybaert, L; Schepers, E; Vanholder, R | 1 |
Brasacchio, D; Chin-Dusting, J; Cooper, ME; Coughlan, MT; Forbes, JM; Harris, E; Kaye, D; Paavonen, K; Soro-Paavonen, A; Thomas, MC; Tong, DC; Venardos, K; Zhang, WZ | 1 |
Förstermann, U | 1 |
Máñez, S; Marín, M | 1 |
Bassareo, PP; Deidda, M; Fanos, V; Flore, G; Manconi, E; Melis, A; Mercuro, G; Puddu, M | 1 |
Barroso, M; Blom, HJ; Castro, R; de Almeida, IT; Esse, R; Gomes, AQ; Gonçalves, I; Jakobs, C; Loscalzo, J; Rivera, I; Rocha, MS; Teerlink, T | 1 |
Bleich, S; Frieling, H; Haschemi-Nassab, M; Hillemacher, T; Kornhuber, J; Leitmeier, V; Rhein, M | 1 |
Colak, Y; Coskunpinar, E; Doganay, L; Kahraman, OT; Mesci, B; Ozturk, O; Senates, E; Tuncer, I; Ulasoglu, C; Yesil, A; Yilmaz, Y | 1 |
Asif, M; Mangoni, AA; McEvoy, M; Soiza, RL | 1 |
McCarty, MF | 1 |
Stanger, O; Stühlinger, MC | 1 |
Sela, BA | 1 |
Jia, SJ; Jiang, DJ; Li, YJ; Yan, J; Yuan, Q; Zhou, Z | 1 |
Wang, YQ; Zheng, YN | 1 |
Cooke, JP; Konishi, H; Sydow, K | 1 |
Sim, AS; Wang, J; Wang, XL; Wilcken, DE | 1 |
Desai, A; Warren, JS; Zhao, Y | 1 |
Chin, C; Cooke, JP; Fearon, WF; Holweg, C; Lewis, DB; Luikart, H; Mocarski, ES; Potena, L; Sydow, K; Valantine, HA; Weisshaar, D | 1 |
Maxwell, AJ | 1 |
6 review(s) available for n,n-dimethylarginine and Vascular Diseases
Article | Year |
---|---|
Nitric oxide and oxidative stress in vascular disease.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Antioxidants; Arginine; Aryldialkylphosphatase; Biopterins; Calcium; Cardiovascular Diseases; Catalase; Electron Transport; Glutathione Peroxidase; Heme Oxygenase (Decyclizing); Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Mitochondria; NADPH Oxidases; Nitric Oxide; Nitric Oxide Synthase Type III; Oxidative Stress; Phosphorylation; Protein Multimerization; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Risk Factors; Superoxide Dismutase; Superoxides; Thioredoxins; Vascular Diseases; Xanthine Oxidase | 2010 |
Pharmacological interventions on asymmetric dimethylarginine, a clinical marker of vascular disease.
Topics: Adrenergic Antagonists; Angiotensins; Arginine; Diabetes Complications; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hyperhomocysteinemia; Hypertension; Kidney Diseases; Microcirculation; Nitric Oxide Synthase Type III; Peroxisome Proliferator-Activated Receptors; Receptors, Cytoplasmic and Nuclear; Vascular Diseases | 2011 |
Asymmetric dimethylarginine: a possible link between vascular disease and dementia.
Topics: Arginine; Brain; Dementia; Endothelium; Enzyme Inhibitors; Humans; Neuroprotective Agents; Nitric Oxide; Oxidative Stress; Risk Factors; Vascular Diseases | 2013 |
Asymmetric dimethyl-L-arginine (ADMA): a possible link between homocyst(e)ine and endothelial dysfunction.
Topics: Animals; Arginine; Arteriosclerosis; Endothelium, Vascular; Homocysteine; Humans; Hyperhomocysteinemia; Nitric Oxide; Vascular Diseases | 2005 |
Asymmetric dimethylarginine (ADMA) in vascular, renal and hepatic disease and the regulatory role of L-arginine on its metabolism.
Topics: Arginine; Citrulline; Dietary Supplements; Hepatocytes; Homocysteine; Humans; Kidney Diseases; Liver Diseases; Nitric Oxide Synthase; Obesity; Risk Factors; Vascular Diseases | 2007 |
Mechanisms of dysfunction of the nitric oxide pathway in vascular diseases.
Topics: Animals; Arginine; Endothelium, Vascular; Humans; Kinetics; Nitric Oxide; Nitric Oxide Synthase; Polymorphism, Genetic; Signal Transduction; Vascular Diseases | 2002 |
1 trial(s) available for n,n-dimethylarginine and Vascular Diseases
Article | Year |
---|---|
Low-fat milk ingestion prevents postprandial hyperglycemia-mediated impairments in vascular endothelial function in obese individuals with metabolic syndrome.
Topics: Adult; Animals; Area Under Curve; Arginine; Blood Glucose; Brachial Artery; Cross-Over Studies; Diet; Dietary Fats; Double-Blind Method; Endothelium, Vascular; Fasting; Female; Humans; Hyperglycemia; Lipid Peroxidation; Male; Malondialdehyde; Metabolic Syndrome; Milk; Nitric Oxide; Obesity; Oryza; Oxidative Stress; Plant Preparations; Postprandial Period; Vascular Diseases; Vasodilation | 2013 |
25 other study(ies) available for n,n-dimethylarginine and Vascular Diseases
Article | Year |
---|---|
Overexpression of alanine-glyoxylate aminotransferase 2 protects from asymmetric dimethylarginine-induced endothelial dysfunction and aortic remodeling.
Topics: Amidohydrolases; Animals; Aorta; Arginine; Blood Pressure; Mice; Transaminases; Vascular Diseases | 2022 |
Asymmetric dimethylarginine correlates with worsening peripheral microangiopathy in systemic sclerosis.
Topics: Adult; Aged; Capillaries; Cross-Sectional Studies; Female; Humans; Male; Microcirculation; Microscopic Angioscopy; Middle Aged; Nails; Scleroderma, Systemic; Vascular Diseases | 2023 |
The effect of haptoglobin genotype on the association of asymmetric dimethylarginine and DDAH 1 polymorphism with diabetic macroangiopathy.
Topics: Amidohydrolases; Diabetes Complications; Diabetes Mellitus, Type 2; Genotype; Haptoglobins; Humans; Vascular Diseases | 2022 |
Association between asymmetric dimethylarginine and sarcopenia in community-dwelling older women.
Topics: Aged; Arginine; Female; Humans; Independent Living; Sarcopenia; Vascular Diseases | 2023 |
Plethysmographic and biochemical markers in the diagnosis of endothelial dysfunction in pediatric acute lymphoblastic leukemia survivors - new applications.
Topics: Adolescent; Arginine; Biomarkers; C-Reactive Protein; Child; E-Selectin; Endothelium, Vascular; Female; Humans; Male; Plethysmography; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prospective Studies; Risk Factors; Vascular Diseases | 2018 |
Homoarginine/ADMA ratio and homoarginine/SDMA ratio as independent predictors of cardiovascular mortality and cardiovascular events in lower extremity arterial disease.
Topics: Aged; Arginine; Biomarkers; Cardiovascular Diseases; Cardiovascular System; Female; Homoarginine; Humans; Incidence; Lower Extremity; Male; Middle Aged; Prospective Studies; Risk Factors; Vascular Diseases | 2018 |
Involvement of advanced glycation end product-induced asymmetric dimethylarginine generation in endothelial dysfunction.
Topics: Aged; Amidohydrolases; Arginine; Atherosclerosis; Cells, Cultured; Diabetic Nephropathies; Endothelial Cells; Female; Glycation End Products, Advanced; Humans; Male; Middle Aged; Nitric Oxide; Reactive Oxygen Species; Vascular Diseases | 2013 |
Asymmetric dimethylarginine (ADMA) and soluble vascular cell adhesion molecule 1(sVCAM-1) as circulating markers for endothelial dysfunction in patients with pheochromocytoma.
Topics: Adrenal Gland Neoplasms; Adult; Aged; Arginine; Biomarkers; Blood Glucose; Blood Pressure; Catecholamines; Endothelium, Vascular; Enzyme-Linked Immunosorbent Assay; Female; Humans; Hypertension; Lipids; Male; Middle Aged; Pheochromocytoma; Vascular Cell Adhesion Molecule-1; Vascular Diseases | 2013 |
Soluble TWEAK plasma levels increase after renal transplantation and associate with the improvement of endothelial function.
Topics: Adult; Arginine; Biomarkers; Brachial Artery; C-Reactive Protein; Cytokine TWEAK; Endothelium, Vascular; Female; Humans; Kidney Transplantation; Male; Postoperative Period; Prospective Studies; Renal Insufficiency, Chronic; Tumor Necrosis Factors; Vascular Diseases; Vasodilation | 2013 |
Soluble CD14 is associated with markers of vascular dysfunction in bariatric surgery patients.
Topics: Adipose Tissue; Adult; Age Factors; Arginine; Bariatric Surgery; Biomarkers; Female; Humans; Lipopolysaccharide Receptors; Lipopolysaccharides; Male; Middle Aged; Monocytes; Obesity; Prospective Studies; Risk Factors; Sex Factors; Vascular Diseases | 2015 |
Endothelial dysfunction in subjects with chronic cadmium exposure.
Topics: Arginine; Biomarkers; Cadmium Compounds; Endothelium, Vascular; Environmental Exposure; Female; Glutathione; Humans; Linear Models; Malondialdehyde; Nitrites; Thrombomodulin; Vascular Diseases | 2015 |
Endocan, TGF-beta, and ADMA as Risk Factors for Endothelial Dysfunction and Possible Vascular Disease in Patients with Subclinical Hypothyroidism.
Topics: Adult; Arginine; Biomarkers; Demography; Endothelium, Vascular; Female; Humans; Hypothyroidism; Inflammation; Male; Neoplasm Proteins; Proteoglycans; Risk Factors; Thyroid Function Tests; Transforming Growth Factor beta; Vascular Diseases | 2016 |
Role of symmetric dimethylarginine in vascular damage by increasing ROS via store-operated calcium influx in monocytes.
Topics: Angiotensin-Converting Enzyme Inhibitors; Anticoagulants; Arginine; Calcium; Calcium Channel Blockers; Calcium Channels; Captopril; Edetic Acid; Enzyme Inhibitors; Humans; Imidazoles; Monocytes; N-Formylmethionine Leucyl-Phenylalanine; Reactive Oxygen Species; Respiratory Burst; Thapsigargin; Vascular Diseases | 2009 |
Advanced glycation end-products induce vascular dysfunction via resistance to nitric oxide and suppression of endothelial nitric oxide synthase.
Topics: Animals; Aorta, Thoracic; Arginine; Cattle; Cells, Cultured; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Endothelial Cells; Glycation End Products, Advanced; Hypoglycemic Agents; Male; Nitric Oxide; Nitric Oxide Synthase Type III; Rats; Rats, Sprague-Dawley; Vascular Diseases; Vasodilation; Vasodilator Agents | 2010 |
Could ADMA levels in young adults born preterm predict an early endothelial dysfunction?
Topics: Adolescent; Adult; Arginine; Early Diagnosis; Endothelium, Vascular; Female; Gestational Age; Humans; Infant, Extremely Low Birth Weight; Infant, Low Birth Weight; Infant, Newborn; Male; Predictive Value of Tests; Premature Birth; Vascular Diseases; Young Adult | 2012 |
Cellular hypomethylation is associated with impaired nitric oxide production by cultured human endothelial cells.
Topics: Arginine; Cells, Cultured; Endothelial Cells; Gene Expression Regulation; Human Umbilical Vein Endothelial Cells; Humans; Hyperhomocysteinemia; Methylation; Nitric Oxide; Nitric Oxide Synthase Type III; S-Adenosylhomocysteine; Vascular Diseases | 2012 |
Reduced plasma levels of asymmetric di-methylarginine (ADMA) in patients with alcohol dependence normalize during withdrawal.
Topics: Adult; Alcoholism; Arginine; Diagnostic and Statistical Manual of Mental Disorders; Germany; Homocysteine; Humans; Hyperhomocysteinemia; International Classification of Diseases; Male; Middle Aged; Nitric Oxide Synthase; Pilot Projects; Prospective Studies; Risk Factors; Severity of Illness Index; Substance Withdrawal Syndrome; Time Factors; Vascular Diseases | 2012 |
Assessment of endothelial function in patients with nonalcoholic fatty liver disease.
Topics: Adult; Arginine; Atherosclerosis; Brachial Artery; Carotid Arteries; Carotid Intima-Media Thickness; Case-Control Studies; Early Diagnosis; Endothelium, Vascular; Fatty Liver; Female; Humans; Insulin Resistance; Male; Middle Aged; Non-alcoholic Fatty Liver Disease; Practice Guidelines as Topic; Predictive Value of Tests; Severity of Illness Index; Vascular Diseases; Vasodilation | 2013 |
Vascular endothelium is the organ chiefly responsible for the catabolism of plasma asymmetric dimethylarginine--an explanation for the elevation of plasma ADMA in disorders characterized by endothelial dysfunction.
Topics: Amidohydrolases; Arginine; Biomarkers; Catalysis; Clinical Trials as Topic; Endothelium, Vascular; Evidence-Based Medicine; Humans; Models, Cardiovascular; Oxidative Stress; Vascular Diseases | 2004 |
[ADMA (asymmetric dimethylarginine)--the inhibitor of nitric oxide (NO) synthesis: a new marker for vascular pathology].
Topics: Arginine; Biomarkers; Humans; Nitric Oxide; Nitric Oxide Synthase; Vascular Diseases; Vasoconstriction | 2005 |
Involvement of DDAH/ADMA/NOS pathway in nicotine-induced endothelial dysfunction.
Topics: Amidohydrolases; Animals; Arginine; Calcium; Endothelium, Vascular; Humans; Male; Nicotine; Nitric Oxide Synthase; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; RNA, Messenger; Vascular Diseases | 2006 |
[Dimethylarginine dimethylaminohydrolase and endothelium dysfunction].
Topics: Amidohydrolases; Animals; Arginine; Endothelium, Vascular; Humans; Vascular Diseases | 2006 |
Dimethylarginine dimethylaminohydrolase promotes endothelial repair after vascular injury.
Topics: Amidohydrolases; Animals; Arginine; Cell Proliferation; Disease Models, Animal; Endothelium, Vascular; Enzyme Induction; Femoral Artery; Humans; Immunohistochemistry; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Neovascularization, Physiologic; Nitric Oxide; Probability; Random Allocation; Sensitivity and Specificity; Species Specificity; Vascular Diseases | 2007 |
Human recombinant erythropoietin augments serum asymmetric dimethylarginine concentrations but does not compromise nitric oxide generation in mice.
Topics: Amidohydrolases; Animals; Arginine; Base Sequence; Cells, Cultured; DNA Primers; Endothelial Cells; Epoetin Alfa; Erythropoietin; Humans; Kidney; Kidney Failure, Chronic; Liver; Male; Mice; Mice, Inbred BALB C; Nitric Oxide; Nitric Oxide Synthase Type II; Recombinant Proteins; Up-Regulation; Vascular Diseases | 2008 |
Asymmetric dimethylarginine and cardiac allograft vasculopathy progression: modulation by sirolimus.
Topics: Adult; Aged; Arginine; Biomarkers; Heart Transplantation; Humans; Hyperplasia; Immunosuppressive Agents; Longitudinal Studies; Middle Aged; Sirolimus; Transplantation, Homologous; Tunica Intima; Ultrasonography; Vascular Diseases | 2008 |